4595 Stock Overview
Researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Mizuho Medy Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,630.00 |
52 Week High | JP¥1,945.00 |
52 Week Low | JP¥1,460.00 |
Beta | 0.88 |
11 Month Change | -0.37% |
3 Month Change | 0.80% |
1 Year Change | -12.95% |
33 Year Change | 28.19% |
5 Year Change | 9.88% |
Change since IPO | 626.06% |
Recent News & Updates
Shareholder Returns
4595 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | 0.8% | -0.7% | -0.5% |
1Y | -13.0% | 14.4% | 10.8% |
Return vs Industry: 4595 underperformed the JP Medical Equipment industry which returned 14.4% over the past year.
Return vs Market: 4595 underperformed the JP Market which returned 10.8% over the past year.
Price Volatility
4595 volatility | |
---|---|
4595 Average Weekly Movement | 2.4% |
Medical Equipment Industry Average Movement | 3.9% |
Market Average Movement | 3.8% |
10% most volatile stocks in JP Market | 7.6% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4595 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4595's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1977 | 180 | Fuminari Karakawa | www.mizuho-m.co.jp |
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits.
Mizuho Medy Co.,Ltd. Fundamentals Summary
4595 fundamental statistics | |
---|---|
Market cap | JP¥31.05b |
Earnings (TTM) | JP¥3.50b |
Revenue (TTM) | JP¥10.99b |
8.9x
P/E Ratio2.8x
P/S RatioIs 4595 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4595 income statement (TTM) | |
---|---|
Revenue | JP¥10.99b |
Cost of Revenue | JP¥3.09b |
Gross Profit | JP¥7.90b |
Other Expenses | JP¥4.40b |
Earnings | JP¥3.50b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 183.58 |
Gross Margin | 71.90% |
Net Profit Margin | 31.83% |
Debt/Equity Ratio | 0% |
How did 4595 perform over the long term?
See historical performance and comparisonDividends
9.2%
Current Dividend Yieldn/a
Payout RatioDoes 4595 pay a reliable dividends?
See 4595 dividend history and benchmarksMizuho MedyLtd dividend dates | |
---|---|
Ex Dividend Date | Dec 27 2024 |
Dividend Pay Date | Mar 31 2025 |
Days until Ex dividend | 32 days |
Days until Dividend pay date | 126 days |
Does 4595 pay a reliable dividends?
See 4595 dividend history and benchmarks